Molecular response to first line nilotinib in a patient with e19a2 BCR-ABL1 chronic myeloid leukemia

Stephen E. Langabeer; Sarah L. McCarron; Peig Carroll; Johanna Kelly; Michael O'Dwyer; Eibhlin Conneally

doi:10.1016/j.leukres.2011.05.010

Molecular response to first line nilotinib in a patient with e19a2 BCR-ABL1 chronic myeloid leukemia

Stephen E. Langabeer
, Sarah L. McCarron
, Peig Carroll
, Johanna Kelly
, Michael O'Dwyer
, Eibhlin Conneally

Medicine

Research output: Contribution to a Journal (Peer & Non Peer) › Letter › peer-review

11 Citations (Scopus)

Original language	English
Pages (from-to)	e169-e170
Journal	Leukemia Research
Volume	35
Issue number	9
DOIs	https://doi.org/10.1016/j.leukres.2011.05.010
Publication status	Published - Sep 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.leukres.2011.05.010

Cite this

@article{50b8f0664f5a4306b6bd3689d7aee717,

title = "Molecular response to first line nilotinib in a patient with e19a2 BCR-ABL1 chronic myeloid leukemia",

author = "Langabeer, \{Stephen E.\} and McCarron, \{Sarah L.\} and Peig Carroll and Johanna Kelly and Michael O'Dwyer and Eibhlin Conneally",

year = "2011",

month = sep,

doi = "10.1016/j.leukres.2011.05.010",

language = "English",

volume = "35",

pages = "e169--e170",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier Ltd",

number = "9",

}

TY - JOUR

T1 - Molecular response to first line nilotinib in a patient with e19a2 BCR-ABL1 chronic myeloid leukemia

AU - Langabeer, Stephen E.

AU - McCarron, Sarah L.

AU - Carroll, Peig

AU - Kelly, Johanna

AU - O'Dwyer, Michael

AU - Conneally, Eibhlin

PY - 2011/9

Y1 - 2011/9

UR - https://www.scopus.com/pages/publications/80051473724

U2 - 10.1016/j.leukres.2011.05.010

DO - 10.1016/j.leukres.2011.05.010

M3 - Letter

SN - 0145-2126

VL - 35

SP - e169-e170

JO - Leukemia Research

JF - Leukemia Research

IS - 9

ER -

Molecular response to first line nilotinib in a patient with e19a2 BCR-ABL1 chronic myeloid leukemia

UN SDGs

Access to Document

Other files and links

Cite this